Latest news
P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements - TradingViewTradingView · Mon, 10 Aug 2026 20:19:47 GMTACH Looks 49.4% Undervalued on GF Value™ Amid Revenue and EBITDA Forecast Revision - GuruFocusGuruFocus · Mon, 10 Aug 2026 13:21:41 GMTPK: Strong Q2 2026 results with higher RevPAR, EBITDA, and raised full-year outlook amid robust demand - TradingViewTradingView · Thu, 06 Aug 2026 21:25:11 GMTMWA: Record sales, margin expansion, and raised EBITDA guidance amid resilient municipal demand - TradingViewTradingView · Thu, 06 Aug 2026 16:41:23 GMTOEC: Specialty segment drives sequential EBITDA growth; guidance and free cash flow outlook raised - TradingViewTradingView · Thu, 06 Aug 2026 13:48:30 GMTESAB: Record sales and EBITDA, boosted by Eddyfi, drive raised 2026 outlook amid robust equipment growth - TradingViewTradingView · Thu, 06 Aug 2026 13:29:17 GMTMAGN: Record sales and EBITDA growth, strong cash flow, and reaffirmed outlook amid inflation - TradingViewTradingView · Thu, 06 Aug 2026 11:05:09 GMTEvertec Raises 2026 Outlook Amid Strong Q2 Performance - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 21:22:00 GMT